TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 4895340

Group type: EXPERIMENTAL
Intervention: Methoxyflurane
Number of subjects: 1257

Group type: EXPERIMENTAL
Intervention: Trichloroethylene
Number of subjects: 1257

Group type: EXPERIMENTAL
Intervention: Nitrous oxide/oxygen
Number of subjects: 1257
Study: 31200686

Group type: EXPERIMENTAL
Intervention: Online mindfulness-based intervention (MBI)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (waiting period)
Number of subjects: 19
Study: 28521751

Group type: EXPERIMENTAL
Intervention: Integrated psychological and advocacy intervention (Nguvu) with usual care
Number of subjects: 400

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 400
Study: 26364276

Group type: EXPERIMENTAL
Intervention: venlafaxine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: imipramine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 40
Study: 24267039

Group type: EXPERIMENTAL
Intervention: High-MUFA ground beef
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Low-MUFA ground beef
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Single exercise session after washout
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Exercise after low-MUFA ground beef diet
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Exercise after high-MUFA ground beef intervention
Number of subjects: 17

Group type: COMPARATOR
Intervention: Exercise and high-MUFA diet
Number of subjects: 17
Study: 21962806

Group type: EXPERIMENTAL
Intervention: Iron supplementation
Number of subjects: 6

Group type: COMPARATOR
Intervention: No iron supplementation
Number of subjects: 6
Study: 18815569

Group type: EXPERIMENTAL
Intervention: Experimental group (n = 60) performed the flamingo balance test with two additional trials every 3 days.
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (n = 70) performed the flamingo balance test without additional trials.
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both groups underwent a retention trial 1 week later after the final trial.
Number of subjects: 130
Study: 16683434

Group type: EXPERIMENTAL
Intervention: Solis fixation
Number of subjects: 104

Group type: COMPARATOR
Intervention: Titanium plate fixation
Number of subjects: 104
Study: 14594148

Group type: EXPERIMENTAL
Intervention: 10 mg oral methadone (5 mg bd)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 20 mg oral methadone (10 mg bd)
Number of subjects: 18
Study: 10885044

Group type: EXPERIMENTAL
Intervention: Free treatment (90 days of substance abuse treatment)
Number of subjects: 362

Group type: EXPERIMENTAL
Intervention: Free treatment
Number of subjects: 362

Group type: COMPARATOR
Intervention: Paid treatment
Number of subjects: 362
Study: 9374236

Group type: EXPERIMENTAL
Intervention: Green tea 3.6 g per day
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Green tea 5.4 g per day
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 28
Study: 1565485

Group type: EXPERIMENTAL
Intervention: Head tilted contralateral to the side of lesion
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Head extension
Number of subjects: 48

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 48
Study: 2989571

Group type: COMPARATOR
Intervention: Ensure (0 g/day soy fiber)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Enrich (30 g/day soy fiber)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ensure with 30 g/day soy fiber (diet c)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ensure with 60 g/day soy fiber (diet d)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Self‐selected diet
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: All fiber-containing diets
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ensure diet
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fiber-supplemented diets and self‐selected diet
Number of subjects: 16
Study: 30799392

Group type: EXPERIMENTAL
Intervention: OPF-108 (revised formula)
Number of subjects: 110

Group type: COMPARATOR
Intervention: ELN (previous formula)
Number of subjects: 110

Group type: COMPARATOR
Intervention: OPF-108 and ELN
Number of subjects: 110
Study: 30045764

Group type: EXPERIMENTAL
Intervention: CRISP tool intervention
Number of subjects: 732

Group type: COMPARATOR
Intervention: Standardised information on cancer prevention (Control)
Number of subjects: 732
Study: 26325248

Group type: EXPERIMENTAL
Intervention: Single-use surgical instruments (SteriSpine™ PS Pedicle Screw System)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Reusable instrumentation (older series)
Number of subjects: 49
Study: 24485347

Group type: EXPERIMENTAL
Intervention: Multidimensional Family Therapy (MDFT)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Individual Therapy (IP)
Number of subjects: 450
Study: 22019281

Group type: EXPERIMENTAL
Intervention: Probiotic drink containing 10(10)CFU/d Lactobacillus paracasei (LPC37) + Calcium phosphate (CaP; 1g Ca/d)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Probiotic drink containing 10(10)CFU/d Lactobacillus paracasei (LPC37)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (bread without CaP)
Number of subjects: 32
Study: 20849215

Group type: EXPERIMENTAL
Intervention: Unilateral deep brain stimulation (DBS) to the subthalamic nucleus or globus pallidus internus (GPi)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Bilateral deep brain stimulation (DBS)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Unilateral DBS
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Baseline asymmetry
Number of subjects: 52

Group type: COMPARATOR
Intervention: GPi DBS
Number of subjects: 52
Study: 17996819

Group type: EXPERIMENTAL
Intervention: Continuous aortic flow augmentation using the Orqis Medical Cancion System (up to 1.5 L/min)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Continuous aortic flow augmentation
Number of subjects: 0
Study: 16029228

Group type: EXPERIMENTAL
Intervention: Cobra Perilaryngeal Airway
Number of subjects: 29

Group type: COMPARATOR
Intervention: Classic Laryngeal Mask Airway
Number of subjects: 29
Study: 12297350

Group type: EXPERIMENTAL
Intervention: Defibrillator with a rhythm display
Number of subjects: 60

Group type: COMPARATOR
Intervention: Defibrillator without a rhythm display
Number of subjects: 60
Study: 10356077

Group type: EXPERIMENTAL
Intervention: Dietary folate group (high in vegetables and citrus fruit, approximately 560 micrograms of folate)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Folic acid group (low in folate, approximately 210 micrograms of folate plus 250 micrograms of folic acid daily)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo group (same low-folate diet as the folic acid group plus placebo tablet)
Number of subjects: 66
Study: 8595287

Group type: EXPERIMENTAL
Intervention: Routine antenatal care by general practitioners and midwives
Number of subjects: 1765
Study: 1673133

Group type: EXPERIMENTAL
Intervention: Intravenous metoprolol (15 mg)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 7471621

Group type: EXPERIMENTAL
Intervention: Methapyrilene 20 mg intravenously
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Methapyrilene 50 mg orally
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Methapyrilene 25 mg orally
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 31300183

Group type: EXPERIMENTAL
Intervention: Lay health advisor intervention (one-on-one teaching course)
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Lay health advisor intervention
Number of subjects: 347

Group type: COMPARATOR
Intervention: Control group (leaflet only)
Number of subjects: 347
Study: 28666360

Group type: EXPERIMENTAL
Intervention: Closed-loop control (CLC)
Number of subjects: 44
Study: 26212349

Group type: EXPERIMENTAL
Intervention: Preoperative pain
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Acute postoperative pain-at-rest
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Acute postoperative pain-on-movement
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Chronic pain-at-rest after THR
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Chronic pain-on-movement after TKR
Number of subjects: 638
Study: 24393328

Group type: EXPERIMENTAL
Intervention: Dexamethasone (16-16-12-12-8-4 mg/d)
Number of subjects: 820

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 820
Study: 23032160

Group type: EXPERIMENTAL
Intervention: Tdap-IPV (REPEVAX®)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Tetanus monovalent vaccine (TMV; Vaccin Tétanique Pasteur® or Tetavax®)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Tetanus monovalent vaccine (TMV)
Number of subjects: 456
Study: 19653742

Group type: EXPERIMENTAL
Intervention: Redundant targets (target-target displays)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single target (target-distractor displays)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No targets (distractor-distractor displays)
Number of subjects: 0
Study: 17457706

Group type: COMPARATOR
Intervention: ia 20 ml of 0.25 % bupivacaine at the end of the operation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ia 20 ml of 0.25 % bupivacaine and 100 mg of tramadol at the end of the operation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: ia 100 mg of tramadol diluted in 20 ml of saline solution 30 minutes before skin incision and 20 ml of 0.25% bupivacaine at the end of the operation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Preemptive ia tramadol
Number of subjects: 60
Study: 15243746

Group type: EXPERIMENTAL
Intervention: Group 1 (started at 0900 hours after monitored sleep)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Group 2 (started 12 hours later)
Number of subjects: 29
Study: 12152362

Group type: EXPERIMENTAL
Intervention: Number of alternatives and disablers
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Speaker control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pragmatic type
Number of subjects: 0
Study: 9615981

Group type: EXPERIMENTAL
Intervention: 3 x 500 impulses of low‐energetic extracorporal shock‐wave therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: 3 x 100 impulses of low‐energetic extracorporal shock‐wave therapy
Number of subjects: 50
Study: 7657008

Group type: EXPERIMENTAL
Intervention: Dextrose infusion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 100
Study: 2529521

Group type: EXPERIMENTAL
Intervention: human antiserum to lipopolysaccharide (LPS)
Number of subjects: 60
Study: 355810

Group type: EXPERIMENTAL
Intervention: Heparin (100 international units per kilogram of body weight, subcutaneously every eight hours for two weeks)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 31994374

Group type: EXPERIMENTAL
Intervention: Artichoke leaves and ginger root extracts combination (320 mg) + simethicone (40 mg)
Number of subjects: 50
Study: 31618656

Group type: EXPERIMENTAL
Intervention: Robot-assisted radical cystectomy (RARC)
Number of subjects: 1781

Group type: COMPARATOR
Intervention: Open radical cystectomy (ORC)
Number of subjects: 1781

Group type: EXPERIMENTAL
Intervention: Preoperative hydronephrosis
Number of subjects: 1781

Group type: EXPERIMENTAL
Intervention: Higher hospital volume
Number of subjects: 1781
Study: 30058182

Group type: EXPERIMENTAL
Intervention: Pictorial stimuli
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Textual stimuli
Number of subjects: 145

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 145
Study: 28703605

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: CBT integrated with motivational interviewing (MI)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control group (CBT)
Number of subjects: 85
Study: 26401986

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D (50,000 IU every 5 days for 3 months)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 23611097

Group type: EXPERIMENTAL
Intervention: Continuous blood purification (CBP)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 21501872

Group type: EXPERIMENTAL
Intervention: Early recovery symptom management (SM) telehealth intervention delivered by Health Buddy for 6 weeks
Number of subjects: 232

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 232
Study: 20103833

Group type: EXPERIMENTAL
Intervention: Oral midazolam 0.5 mg/kg (group M)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Clonidine 2 microg/kg (group C2)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Clonidine 4 microg/kg (group C4)
Number of subjects: 45
Study: 17543634

Group type: EXPERIMENTAL
Intervention: Tolvaptan (30 mg/day)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 240
Study: 15090634

Group type: EXPERIMENTAL
Intervention: Pramlintide 120 microg BID
Number of subjects: 498

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 498
Study: 11773803

Group type: EXPERIMENTAL
Intervention: Colostrum delivered by syringe
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Colostrum delivered on a pacifier
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sucrose
Number of subjects: 60

Group type: COMPARATOR
Intervention: Water
Number of subjects: 60

Group type: COMPARATOR
Intervention: Colostrum via syringe
Number of subjects: 60
Study: 9333953

Group type: EXPERIMENTAL
Intervention: Avoidance of intramedullary compression
Number of subjects: 203

Group type: COMPARATOR
Intervention: Standard procedure (without avoidance of intramedullary compression)
Number of subjects: 203
Study: 8343002

Group type: COMPARATOR
Intervention: Dual-lumen 10 French tunneled cuffed silastic central venous access catheter
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Dual-lumen 10 French tunneled cuffed silastic central venous access catheter with a second proximal subcutaneous silver-impregnated cuff
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both catheter types
Number of subjects: 200
Study: 3741095

Group type: EXPERIMENTAL
Intervention: Deep leg veins as femoropopliteal bypass grafts
Number of subjects: 82
Study: 29676975

Group type: EXPERIMENTAL
Intervention: Scotchbond Universal/self-etch (SU_SE)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Prime & Bond Elect/etch-and-rinse (PBE_E&R)
Number of subjects: 63
Study: 27901218

Group type: EXPERIMENTAL
Intervention: Integrated safety catheter
Number of subjects: 169

Group type: COMPARATOR
Intervention: Simple needle catheter
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: 20 Gauge catheter
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Fluid solutions
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 169
Study: 24809360

Group type: EXPERIMENTAL
Intervention: Limited-undermining lipoabdominoplasty
Number of subjects: 18

Group type: COMPARATOR
Intervention: Traditional abdominoplasty with wide undermining
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (Traditional abdominoplasty)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Study group (Limited-undermining lipoabdominoplasty)
Number of subjects: 18
Study: 22607269

Group type: COMPARATOR
Intervention: Single doses of S1RA (5-500 mg, study 101; 500-800 mg, study 106)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Multiple doses of S1RA (50-400 mg once daily for 8 days, study 102)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 175
Study: 20798179

Group type: EXPERIMENTAL
Intervention: Lower-extremity exercise and walking intervention
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (regular foot care, foot care education, and 8 sessions with a physical therapist)
Number of subjects: 79
Study: 18590952

Group type: EXPERIMENTAL
Intervention: Fenfluramine administration in MDD/AUD group
Number of subjects: 169
Study: 12215958

Group type: EXPERIMENTAL
Intervention: Intravenous L-arginine hydrochloride salt
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 9641434

Group type: EXPERIMENTAL
Intervention: Naproxen (500 mg orally twice per day)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Naproxen
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 15378949

Group type: EXPERIMENTAL
Intervention: alpha-interferon (alpha-IFN) administered at a dose of 3 x 10(6) U three times per week until disease progression.
Number of subjects: 73

Group type: COMPARATOR
Intervention: No therapy (control group) for patients who obtained a complete or partial response after FLU therapy.
Number of subjects: 73
Study: 2530145

Group type: EXPERIMENTAL
Intervention: Saccharomyces cerevisiae Hansen CBS 5926 (Perenterol)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 139
Study: 1099894

Group type: EXPERIMENTAL
Intervention: 1 g D-isoascorbic acid
Number of subjects: 210

Group type: COMPARATOR
Intervention: 1 g L-ascorbic acid
Number of subjects: 210

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 210
Study: 31773143

Group type: EXPERIMENTAL
Intervention: Fidaxomicin (suspension or tablets, twice daily for 10 days)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Vancomycin (suspension or tablets, 4 times daily for 10 days)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Fidaxomicin
Number of subjects: 148

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Fidaxomicin and Vancomycin
Number of subjects: 148
Study: 29072214

Group type: EXPERIMENTAL
Intervention: Nonsurgical periodontal treatment
Number of subjects: 19
Study: 26399399

Group type: EXPERIMENTAL
Intervention: Verum acupuncture plus as-needed salbutamol aerosol and/or prednisone tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham acupuncture plus as-needed salbutamol aerosol and/or prednisone tablets
Number of subjects: 0
Study: 23290835

Group type: EXPERIMENTAL
Intervention: VPM1002 (Mycobacterium bovis BCG ΔureC::hly Hm(R)), administered as one intradermal dose, randomized to three escalating doses.
Number of subjects: 80

Group type: COMPARATOR
Intervention: BCG (control group), 10 individuals in each group (BCG-naïve and BCG-immune).
Number of subjects: 80
Study: 20695794

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioural Therapy (CBT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 40
Study: 18380539

Group type: EXPERIMENTAL
Intervention: Folic acid supplementation
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (healthy children)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (DM1)
Number of subjects: 92
Study: 17096618

Group type: EXPERIMENTAL
Intervention: 6-week stress management program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Additional 'refresher' sessions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 14685663

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0
Study: 11357021

Group type: EXPERIMENTAL
Intervention: Laparoscopic‐assisted colectomy
Number of subjects: 97

Group type: COMPARATOR
Intervention: Open colectomy
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Both surgical techniques
Number of subjects: 97
Study: 9149193

Group type: EXPERIMENTAL
Intervention: Long pouch
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Short pouch
Number of subjects: 27

Group type: COMPARATOR
Intervention: Control
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 27
Study: 7714143

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (Ig) 500 mg/kg prior to the next embryo transfer
Number of subjects: 29
Study: 3443063

Group type: EXPERIMENTAL
Intervention: Felodipine 2.5mg bid for 7 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Felodipine 5mg bid for 7 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Felodipine 10mg bid for 1 week
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Felodipine 10mg single dose
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Felodipine 10mg bid
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Felodipine (various doses)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 12
Study: 31248662

Group type: EXPERIMENTAL
Intervention: Veverimer (6 g/day)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study: 29235659

Group type: EXPERIMENTAL
Intervention: Open‐label, protocolized treatment with extended‐release venlafaxine for 12 or more weeks
Number of subjects: 435
Study: 25145693

Group type: EXPERIMENTAL
Intervention: High-dose oral methylprednisolone (oMP)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Intravenous methylprednisolone (ivMP)
Number of subjects: 49
Study: 24432677

Group type: EXPERIMENTAL
Intervention: Needling at right Waiguan (SJ5) in Group A
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Needling at non-acupoint (10 mm beside Waiguan) in Group B
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Comparison between Group A and Group B
Number of subjects: 21
Study: 21452107

Group type: EXPERIMENTAL
Intervention: Grape seed proanthocyanidin extract (GSPE)
Number of subjects: 100
Study: 19015193

Group type: EXPERIMENTAL
Intervention: Intrathecal fentanyl (5K(Fent), L3‐L4)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Saline injection (5K(Plac), L3‐L4)
Number of subjects: 8
Study: 17092242

Group type: EXPERIMENTAL
Intervention: Autologous platelet concentrate (APC) applied in test defects
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control procedure without APC
Number of subjects: 25
Study: 15148011

Group type: EXPERIMENTAL
Intervention: Cochrane Library systematic reviews
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cochrane trials database
Number of subjects: 0
Study: 11549975

Group type: EXPERIMENTAL
Intervention: Low-dose fluticasone propionate (176 or 200 mcg daily) for 6‐26 weeks
Number of subjects: 1614

Group type: EXPERIMENTAL
Intervention: Low-dose fluticasone propionate (100 mcg daily) for 12‐52 weeks
Number of subjects: 1614

Group type: COMPARATOR
Intervention: Low-dose beclomethasone dipropionate (336 mcg daily)
Number of subjects: 1614
Study: 9331520

Group type: EXPERIMENTAL
Intervention: Phenytoin (PHT) prophylaxis
Number of subjects: 15